Live Breaking News & Updates on Pipeline Clinical Program

Stay updated with breaking news from Pipeline clinical program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Steve Cohen Keeps Betting On Biopharma With Purchase Of 119M+ Bionomics Shares - Bionomics (NASDAQ:BNOX), Cybin (AMEX:CYBN)

NY Mets owner billionaire Steve Cohen has bought as many as 119,092,680 ordinary shares of clinical-stage biopharmaceutical company Bionomics Limited (NASDAQ: BNOX) through his Point72 asset management firm, again showing support for the biopharma sector. ....

United States , Steve Cohen , Bionomics Limited , Pipeline Clinical Program , Australian Securities Exchange , Frankfurt Stock Exchange Fra , Frankfurt Stock Exchange , American Depositary Shares , One Step Closer To Being , Social Anxiety Disorder , Track Designations ,

Portage Biotech Announces Results for Fiscal Quarter Ended September 30, 2022

Portage Biotech Announces Results for Fiscal Quarter Ended September 30, 2022
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Relationsgwen Schanker , Relationschuck Padala , American Society Of Clinical Oncology , Owners Of The Company , Merck Co , Portage Biotech Inc , Clinical Development Goals On Producing Nine Phase , Lincoln Park Capital Fund , Company Annual Report On Form , Development Agreement , Society For Immunotherapy Of Cancer , Development Committee , Merck Sharp Dohme Corp , Pipeline Clinical Program , National Cancer Institute Collaboration Research , Wall Street , Updated Data , Clinical Collaboration Agreement Entered , Focused Clinical Development Goals , Producing Nine Phase , Multiple Tumor Types Over , Next Two , Biotech Inc , Asian Waters , Chief Executive Officer ,

Portage Biotech Announces Results for Fiscal Quarter Ended

Updated Data on Phase 1/2 Trial Evaluating PORT-2 Presented at the Society for Immunotherapy of Cancer’s (SITC) Annual Meeting Clinical. ....

United States , Development Agreement , Society For Immunotherapy Of Cancer , American Society Of Clinical Oncology , Development Committee , Merck Co , Portage Biotech Inc , Clinical Development Goals On Producing Nine Phase , Merck Sharp Dohme Corp , Lincoln Park Capital Fund , Pipeline Clinical Program , National Cancer Institute Collaboration Research , Updated Data , Clinical Collaboration Agreement Entered , Focused Clinical Development Goals , Producing Nine Phase , Multiple Tumor Types Over , Next Two , Biotech Inc , Asian Waters , Chief Executive Officer , Clinical Program Highlights , Quarter Ended September , Portage Biotech , Joint Development Committee , Clinical Oncology ,